Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL5630157

O=C(O)C(F)(F)F.ON=C(Nc1ccc(F)c(Cl)c1)c1nonc1CCn1ccnc1

nearest known ligand 0.40

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 1/20 0.40
HSD17B10 Q99714 1/20 0.40
MEN1 O00255 3/20 0.38
KMT2A Q03164 3/20 0.38
LMNA P02545 3/20 0.38
MAPT P10636 3/20 0.38
L3MBTL1 Q9Y468 2/20 0.37
ALDH1A1 P00352 1/20 0.37
CACNA1B Q00975 1/20 0.37
SMN1; SMN2 Q16637 5/20 0.36
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
CYP1A2 P05177 2/20 0.36
CYP3A4 P08684 2/20 0.36
CYP2D6 P10635 2/20 0.36
CYP2C9 P11712 2/20 0.36
CYP2C19 P33261 2/20 0.36
IDO1 P14902 1/20 0.36
TP53 P04637 1/20 0.36
HTT P42858 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL5630146 1.00 ALOX15 (0.40) ALOX15HSD17B10MEN1KMT2ALMNA
SCHEMBL5632786 0.94 ALOX15 (0.40) ALOX15HSD17B10MEN1KMT2ALMNA
SCHEMBL5632784 0.94 ALOX15 (0.40) ALOX15HSD17B10MEN1KMT2ALMNA
Trifluoroacetic Acid SCHEMBL5631784 0.91 MEN1 (0.39) ALOX15HSD17B10MEN1KMT2ALMNA
Trifluoroacetic Acid SCHEMBL5631774 0.91 MEN1 (0.39) ALOX15HSD17B10MEN1KMT2ALMNA
Trifluoroacetic Acid SCHEMBL5632105 0.89 ALOX15 (0.47) ALOX15HSD17B10MEN1KMT2ALMNA
Trifluoroacetic Acid SCHEMBL5632113 0.89 ALOX15 (0.47) ALOX15HSD17B10MEN1KMT2ALMNA
Trifluoroacetic Acid SCHEMBL5632073 0.88 MEN1 (0.38) MEN1KMT2ALMNAMAPTL3MBTL1
Trifluoroacetic Acid SCHEMBL5632063 0.88 MEN1 (0.38) MEN1KMT2ALMNAMAPTL3MBTL1
SCHEMBL5630149 0.87 HSD17B10 (0.40) ALOX15HSD17B10MEN1KMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8951536-B2 N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase INCYTE CORPORATION (US) 2015-02-10 US claimed
US-20130177590-A1 N-HYDROXYAMIDINOHETEROCYCLES AS MODULATORS OF INDOLEAMINE 2,3-DIOXYGENASE INCYTE CORPORATION (US) 2013-07-11 US claimed
US-20070185165-A1 N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase INCYTE CORPORATION 2007-08-09 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130177590-A1 N-HYDROXYAMIDINOHETEROCYCLES AS MODULATORS OF INDOLEAMINE 2,3-DIOXYGENASE IDO1, IDO2, HNMT ALOX15 429/4885HSD17B10 812/4885MEN1 1163/4885
US-20070185165-A1 N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase IDO1, IDO2, HNMT ALOX15 429/4885HSD17B10 812/4885MEN1 1163/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.